We ship from Australia — Australia wide
Osteoporosis Treatment

The world's first clinically approved, non-drug therapy for bone health.

Marodyne LiV uses Low-Intensity Vibration to gently stimulate the body's own natural response — increasing bone mineral density, improving blood flow and building muscle strength. Just 10 minutes a day, at home.

Safe. Effective. Certified.

Marodyne LiV is a medical device (Class IIa) certified and approved by the European Union (MDD 93/42 / EEC Annex II) and registered on the Australian Register of Therapeutic Goods (ARTG 317506). It is the world's only clinically-approved, non-drug treatment of its kind.

Studies have established that standing for just 10 minutes a day on the device encourages bone growth, builds muscle mass and strength, and stimulates blood circulation and lymphatic flow.

At a glance

Frequency
30 Hz
Amplitude
< 0.1 mm
Signal
0.4 g Low-Intensity
Daily use
10 minutes
Classification
Class IIa Medical Device

10 minutes a day. Compounding benefits.

  • Maintain and increase bone mineral density (BMD)
  • Build muscle strength and mass in the legs
  • Stimulate blood circulation and lymphatic flow
  • Improve balance, postural control and coordination
  • Support falls prevention in older adults
  • Reassign stem cells (MSCs) to bone formation
  • Suppress stem cell formation of new fat
  • Boost metabolism to support bones and muscles

Designed for the people who need it most.

Marodyne LiV is tested to deliver benefits across a broad range of patients — from post-menopausal women to children with bone conditions.

  • Older patients with osteoporosis
  • Post-menopausal women with poor bone health
  • People at risk of developing osteoporosis
  • Children and young people with bone-damaging conditions
  • Clinicians seeking non-pharmaceutical falls prevention

Backed by 40 years of science.

The technology inside Marodyne LiV was developed in collaboration with NASA and the National Institutes of Health (NIH), led by Professor Dr. Clinton Rubin — one of the world's foremost biomedical engineers. It represents nearly 40 years of research and $70m of investment.

Development is supervised by a scientific advisory board with leading experts in biomedicine, orthopaedics, osteoporosis, metabolism, rehabilitation medicine and stem cell research.

View the clinical evidence
Australian woman using Marodyne LiV at home for osteoporosis and bone density support
Home-based therapy

A 10-minute daily habit for lifelong bone health.

Osteoporosis is often called the silent disease — 1 in 2 Australian women and 1 in 3 men over 60 will experience a fracture linked to poor bone health. Marodyne LiV brings clinically approved Low-Intensity Vibration therapy into the home, so you can support bone mineral density, muscle strength and balance on your own schedule — without drugs, injections or gym visits.

It's used daily by post-menopausal women, adults with osteopenia and osteoporosis, cancer survivors, elite athletes and clinicians across Australia and New Zealand.

NASA & NIH Research

Born from spaceflight science.

LiV technology was originally developed to protect astronauts from the rapid bone and muscle loss that occurs in microgravity. Over 40 years of research led by Professor Clinton Rubin at Stony Brook University — funded by the NIH, NASA and the US Department of Defense — translated that science into a safe, certified medical device that Australians can now use at home.

  • • 60+ peer-reviewed clinical studies
  • • Class IIa CE-marked medical device
  • • ARTG 317506 registered in Australia
  • • Made in Germany to medical-grade standards
Clinicians reviewing DEXA bone density scan results in a research laboratory
3D bone microstructure showing dense trabecular network strengthened by LiV therapy
How LiV supports your skeleton

Bone remodelling, without the side-effects.

The 0.4g, 30 Hz signal mimics the natural postural muscle contractions your body loses with age and inactivity. This mechanical stimulus activates osteoblasts (bone-building cells), directs stem cells toward bone rather than fat, and improves blood circulation and lymphatic flow — all core drivers of healthy bone remodelling.

Explore the clinical evidence →